Alpha Cognition Inc.
ACOG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001655923
In the last 90 days, Alpha Cognition Inc. insiders filed 7 open-market purchases and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $75.7M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Alpha Cognition Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 27 | 25 | −2 |
| Shares | 9.91M | 10.5M | +623.4K (+6.3%) |
| Value | $64.4M | $57.8M | −$6.59M (−10.2%) |
New holders (3)
Institutions that held Alpha Cognition Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 10,000 | $54.9K | 0.00% |
| Jones Financial Companies LLLP | 100 | $508 | 0.00% |
| Harbour Investments, Inc. | 4 | $25 | 0.00% |
Sold out (5)
Institutions that held Alpha Cognition Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Marshall Wace, LLP | 53,203 | $345.8K |
| Susquehanna International Group, LLP | 34,706 | $225.6K |
| Quadrature Capital Ltd | 12,501 | $81.3K |
| Green Alpha Advisors, LLC | 11,126 | $72.3K |
| The PNC Financial Services Group, Inc. | 120 | $780 |